FABP2 Ala54Thr polymorphism and diabetes in Chilean elders

被引:23
作者
Albala, Cecilia
Villarroel, Ana
Santos, Jose Luis
Angel, Barbara
Lera, Lydia
Liberman, Claudio
Sanchez, Hugo
Perez-Bravo, Francisco
机构
[1] Univ Chile, Publ Hlth Nutr Unit, Chron Dis & Genet Epidemiol Res Lab, INTA, El Libiano 5524, Chile
[2] Univ Chile, Dept Endocrinol, Clin Hosp, Fac Med, Santiago, Chile
关键词
FABP2; polymorphism; diabetes; elders;
D O I
10.1016/j.diabres.2006.12.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The FABP2 Ala54Thr polymorphism has been associated with insulin resistance and diabetes in several populations. The aim of this study was to estimate the prevalence of FABP2 genotypes in 223 Chilean subjects (136 women and 87 men aged 65-79 years) and its association with type 2 diabetes in a. 4 years follow-up. Methods: Glucose, Insulin and lipids were measured in fasting plasma samples. Insulin resistance was estimated through the homeostasis model assessment. Diabetes was diagnosed according ADA criteria. The Ala54Thr allelic variant was determined by polymerase chain reaction and restriction fragment-length polymorphism analysis. Logistic regression techniques were used to assess gene-disease associations. Results: Genotype frequencies were estimated as 30.5, 49.3 and 20.2% for the Ala/Ala, Alar/Thr and Thr/Thr, respectively. The crude OR for the association between Thr54 carriers and diabetes was estimated as 2.18 (1.12-4.24). The corresponding OR for the association between ThA-54 carriers with Metabolic syndrome was 1.06 (0.59-1.88). After adjustment by BMI and age, a significant association persists for Thr54Thr carriers and diabetes (OR 2.70; 95% CI 1.113-6.527). The 4-year cumulative incidence of diabetes was higher in Thr carriers than in non-carriers (20.1 % versus 8.5%; p < 0.04). The adjusted association between Thr54Thr polymorphism and diabetes incidence was OR 3.84 (95% CI: 1.140-12.910) Conclusion: Our results strongly suggest an association between the Ala54Thr polymorphism of FABP2 with diabetes, revealing a genetic dosage effect regarding its association with diabetes in Chilean elders (C) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:245 / 250
页数:6
相关论文
共 35 条
[1]  
Ågren JJ, 2001, AM J CLIN NUTR, V73, P31
[2]   The health, well-being, and aging ("SABE") survey:: Methodology applied and profile of the study population [J].
Albala, C ;
Lebrao, ML ;
Díaz, EML ;
Ham-Chande, R ;
Hennis, AJ ;
Palloni, A ;
Peláez, M ;
Pratts, O .
REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH, 2005, 17 (5-6) :307-322
[3]   Intestinal FABP2 A54T polymorphism:: Association with insulin resistance and obesity in women [J].
Albala, C ;
Santos, JL ;
Cifuentes, M ;
Villarroel, AC ;
Lera, L ;
Liberman, C ;
Angel, B ;
Pérez-Bravo, F .
OBESITY RESEARCH, 2004, 12 (02) :340-345
[4]   AN AMINO-ACID SUBSTITUTION IN THE HUMAN INTESTINAL FATTY-ACID-BINDING PROTEIN IS ASSOCIATED WITH INCREASED FATTY-ACID-BINDING, INCREASED FAT OXIDATION, AND INSULIN-RESISTANCE [J].
BAIER, LJ ;
SACCHETTINI, JC ;
KNOWLER, WC ;
EADS, J ;
PAOLISSO, G ;
TATARANNI, PA ;
MOCHIZUKI, H ;
BENNETT, PH ;
BOGARDUS, C ;
PROCHAZKA, M .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (03) :1281-1287
[5]   A polymorphism in the human intestinal fatty acid binding protein alters fatty acid transport across Caco-2 cells [J].
Baier, LJ ;
Bogardus, C ;
Sacchettini, JC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (18) :10892-10896
[6]   Effects of the FABP2 A54T mutation on triglyceride metabolism of viscerally obese men [J].
Berthier, MT ;
Couillard, C ;
Prud'homme, D ;
Nadeau, A ;
Bergeron, J ;
Tremblay, A ;
Després, JP ;
Vohl, MC .
OBESITY RESEARCH, 2001, 9 (11) :668-675
[7]  
Boullu-Sanchis S, 1999, DIABETES METAB, V25, P150
[8]   FABP2 genotype is associated with insulin sensitivity in older women [J].
Brown, MD ;
Shuldiner, AR ;
Ferrell, RE ;
Weiss, EP ;
Korytkowski, MT ;
Zmuda, JM ;
McCole, SD ;
Moore, GE ;
Hagberg, JM .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2001, 50 (09) :1102-1105
[9]   The T 54 allele of the intestinal fatty acid-binding protein 2 is associated with a parental history of stroke [J].
Carlsson, M ;
Orho-Melander, M ;
Hedenbro, J ;
Almgren, P ;
Groop, LC .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (08) :2801-2804
[10]  
Chalmers J, 1999, J HYPERTENS, V17, P151